Lunch with Guido Brera, the golden boy of finance
Do not miss the opportunity to meet Guido Maria Brera and discover everything there is to know about finance
Guido Maria Brera, 46, was a successful banker and today is a financier. He works for an asset management company and is also the author of the bestseller I Diavoli. He is married to Caterina Balivo and he has 3 children.
By winning this auction, you will have the opportunity to have lunch with him and discover the secrets of the trade. Spend time with a man who was among the most important asset managers in Europe, before founding his own asset management company which now has more than 7 billion euros under management.
Guido is supporting Fondazione Telethon.
Conditions: the winner will be notified via email. The auction is inclusive of the experience described above, any other kind of spending shall be borne by the winner. The experience will be held in Milan, on a date to be determined based on the availability of the winner and Guido Brera. Need more information? Email firstname.lastname@example.org or call us on 0203 301 5800.
Live a Dream, Make a Change
Since 1990, we have been investing in the best research to find cures for rare genetic diseases. Because these diseases are so rare, often times there is no research being done on them, never mind therapeutic options or a cure.
We want to change this state of affairs because we believe that every person is worth fighting for.
We focus on transforming the results of excellent scientific research projects, selected and supported over time, into accessible treatments.
Finding a cure is not the final destination but a new starting point. We have to make every possible effort to guarantee that successful forms of treatment discovered through the research funded by Telethon are then made available to all patients.
For this reason we also work to develop partnerships with public health care institutions and pharmaceutical companies, so that the results of our research will translate to treatment and medicine accessible to all patients worldwide.